Key issues for GPs: Q&A

September 2004
Pulse;9/20/2004, Vol. 64 Issue 37, special section p6
Presents several queries on issues related to medical care. Details on the experiences of various general practitioners; Number of patients taking statin drugs; Causes of several diseases.


Related Articles

  • Statins to go OTC by June, say ministers. Doult, Bill; Polak, Monika; Baines, Emma // GP: General Practitioner;11/17/2003, p1 

    Statins could become available over the counter within the next six months, Great Britain Department of Health is expected to announce today. The Medicines and Healthcare Products Regulatory Agency and the Committee on Safety of Medicines are to consult on whether simvastatin, which came off...

  • JBS pushes for MOTs at age 40.  // Pulse;11/19/2005, Vol. 65 Issue 45, p3 

    The article reports on the new guidelines of the Joint British Societies that are aimed at identifying the huge numbers of extra patients who will now be eligible for statins in Great Britain. It advocates the need for general practitioners to assess every adult over forty for their risk of...

  • Confusion over statin dispute 'risks patient trust.  // GP: General Practitioner;7/7/2014, p50 

    The article reports that the benefits and harms of statin treatment risks were undermining confidence in the treatment decisions of general practitioners (GPs) according to a survey conducted by "General Practitioner", and some GPs and patients were confused by the dispute about statin treatment.

  • Statin switch ordered. Iacobucci, Gareth // Pulse;10/26/2006, Vol. 66 Issue 40, p8 

    The article reports on the schemes in East of England which urged General Practitioners (GP) to contact their patients that used statins and advised them to switch to generic simvastatin as part of severe cost-cutting plans. Another scheme required the GPs to double the proportion of patients on...

  • Clinical: Statins lead the drive in primary CHD prevention. Minhas, Rubin // GP: General Practitioner;8/19/2005, p43 

    Discusses the impact of a new directive issued by NICE regarding treatment of congenital heart disease (CHD) patients in Great Britain on physicians. Information that NICE has established that treating patients at 20 per cent CHD risk or greater is a cost-effective use of NHS resources; Reasons...

  • QOF: Statins target threatens QOF. Chan, Siobhan // GP: General Practitioner;2/9/2015, p21 

    The article discusses how the proposed Quality and Outcomes Framework (QOF) targets for promoting the use of statin at lower cardiac risk level affect QOF's credibility and the patients according to the General Practitioners Committee (GPC). Topics covered include details relating to the...

  • Third of heart patients missing out on statins. Goodman, Eleanor // Pulse;1/25/2007, Vol. 67 Issue 3, p23 

    The article reports on the new research that as many as one third of patients with coronary heart disease continue to miss out on statins, because the general practitioner (GP) failed to incentivize their treatment. Researchers advise that the proportion on the drugs remained disheartingly low,...

  • Dual therapy 'last resort' for CHD. Hensler, Paula // GP: General Practitioner;5/3/2004, p27 

    Statin and ezetimibe combination therapy should only be used as a last resort for high-risk coronary heart disease patients, according to general practitioners (GPs) with an interest in cardiology. However, GPs with an interest in cardiology say combination therapy with the new drug should be...

  • Are physical symptoms among survivors of a disaster presented to the general practitioner? A comparison between self-reports and GP data. van den Berg, Bellis; Yzermans, C. Joris; van der Velden, Peter G.; Stellato, Rebecca K.; Lebret, Erik; Grievink, Linda // BMC Health Services Research;2007, Vol. 7, p150 

    Background: Most studies examining medically unexplained symptoms (MUS) have been performed in primary or secondary care and have examined symptoms for which patients sought medical attention. Disasters are often described as precipitating factors for MUS. However, health consequences of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics